Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  recombinant vaccinia prostate-specific antigen vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Phase II Randomized Study of Radiotherapy With or Without Vaccination Comprising Recombinant Vaccinia-PSA and rV-B7.1 Plus Recombinant Fowlpox-PSA Vaccine in Patients With Localized Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-00-C-0154, NCI-NMOB-B00-021, NCI-894, 894, NCT00020228
Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000068106, NCI-00-C-0137, MB-NAVY-99-04, NCI-T99-0097, T99-0097, NCT00020254
Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000256919, NCI-02-C-0218, NCI-5319, 5319, NCT00045227
PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067036, E-7897, NCT00003871
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000065275, DFCI-96079, NCI-T95-0086H, T95-0086, NCT00004029
Start Over